Loading...

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease

Intestinal Behçet’s disease is a rare, immune-mediated chronic intestinal inflammatory disease; therefore, clinical trials to optimize the management and treatment of patients are scarce. Moreover, intestinal Behçet’s disease is difficult to treat and often requires surgery because of the failure of...

Full description

Saved in:
Bibliographic Details
Published in:Gut Liver
Main Authors: Park, Jihye, Cheon, Jae Hee
Format: Artigo
Language:Inglês
Published: Editorial Office of Gut and Liver 2018
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254627/
https://ncbi.nlm.nih.gov/pubmed/29788675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl17462
Tags: Add Tag
No Tags, Be the first to tag this record!